ImmunityBio (IBRX) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: November 29, 2023 (07:54)
Sector: HealthcareThe share price of ImmunityBio, Inc. (IBRX) now
50/200 Day Moving Average: $2.397 / $2.402
This figure corresponds to the Average Price over the previous 50/200 days. For ImmunityBio stocks, the 50-day moving average is the support level today.
For ImmunityBio stocks, the 200-day moving average is the support level today.
Are you interested in ImmunityBio, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunityBio stock price in 2023, 2024, 2025, 2026, 2027. How much will one ImmunityBio share be worth in 2023 - 2027?
When should I take profit in ImmunityBio stock? When should I record a loss on ImmunityBio stock? What are analysts' forecasts for ImmunityBio stock? What is the future of ImmunityBio stock? We forecast ImmunityBio stock performance using neural networks based on historical data on ImmunityBio stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
ImmunityBio stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunityBio shares. This happens once a day.
Historical and forecast chart of ImmunityBio stock
The chart below shows the historical price of ImmunityBio stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunityBio stock price can be found in the table below.
Long-term forecasts by years.
ImmunityBio, Inc., an immunotherapy company, is developing a memory T-cell cancer vaccine to fight several types of tumors without the use of high-dose chemotherapy. He is developing albumin-linked chemotherapy (aldoxorubicin), a new cytokine superagonist IL-15 (N-803), checkpoint inhibitors, macrophage polarizing peptides, bispecific fusion proteins targeting TGFb and IL-12, adenovirus treatment and yeast vaccine. targeting tumor-associated antigens and neoepitopes. ImmunityBio Inc.
ImmunityBio daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 01 | 4.27 | 4.15 | 4.38 | 5.45 |
| Dec 02 | 4.19 | 4.11 | 4.29 | 4.49 |
| Dec 03 | 4.14 | 4.02 | 4.22 | 4.94 |
| Dec 04 | 3.94 | 3.78 | 4.06 | 7.19 |
| Dec 05 | 3.85 | 3.77 | 3.95 | 5.01 |
| Dec 06 | 4.00 | 3.90 | 4.10 | 4.96 |
| Dec 07 | 4.06 | 3.95 | 4.20 | 6.37 |
| Dec 08 | 4.06 | 3.91 | 4.14 | 6.02 |
| Dec 09 | 4.08 | 4.00 | 4.15 | 3.62 |
| Dec 10 | 3.99 | 3.83 | 4.09 | 6.82 |
| Dec 11 | 3.93 | 3.80 | 3.97 | 4.65 |
| Dec 12 | 4.11 | 4.06 | 4.24 | 4.61 |
| Dec 13 | 4.02 | 3.86 | 4.08 | 5.57 |
| Dec 14 | 4.00 | 3.85 | 4.07 | 5.88 |
| Dec 15 | 4.02 | 3.96 | 4.17 | 5.48 |
| Dec 16 | 3.96 | 3.86 | 4.10 | 6.04 |
| Dec 17 | 4.13 | 3.98 | 4.17 | 4.82 |
| Dec 18 | 4.25 | 4.15 | 4.38 | 5.68 |
| Dec 19 | 4.11 | 3.98 | 4.17 | 4.80 |
| Dec 20 | 4.16 | 4.11 | 4.32 | 5.00 |
| Dec 21 | 4.16 | 4.07 | 4.32 | 6.02 |
| Dec 22 | 4.14 | 4.04 | 4.21 | 4.25 |
| Dec 23 | 4.32 | 4.15 | 4.47 | 7.70 |
| Dec 24 | 4.51 | 4.42 | 4.57 | 3.58 |
| Dec 25 | 4.71 | 4.61 | 4.82 | 4.76 |
| Dec 26 | 4.61 | 4.48 | 4.66 | 3.91 |
| Dec 27 | 4.69 | 4.52 | 4.82 | 6.64 |
| Dec 28 | 4.63 | 4.49 | 4.69 | 4.59 |
| Dec 29 | 4.71 | 4.57 | 4.86 | 6.50 |
| Dec 30 | 4.67 | 4.59 | 4.77 | 3.87 |
ImmunityBio Daily Price Targets
ImmunityBio Stock Forecast 12-01-2023.
Forecast target price for 12-01-2023: $4.27.
Positive dynamics for ImmunityBio shares will prevail with possible volatility of 5.168%.
Pessimistic target level: 4.15
Optimistic target level: 4.38
ImmunityBio Stock Forecast 12-02-2023.
Forecast target price for 12-02-2023: $4.19.
Negative dynamics for ImmunityBio shares will prevail with possible volatility of 4.299%.
Pessimistic target level: 4.11
Optimistic target level: 4.29
ImmunityBio Stock Forecast 12-03-2023.
Forecast target price for 12-03-2023: $4.14.
Negative dynamics for ImmunityBio shares will prevail with possible volatility of 4.711%.
Pessimistic target level: 4.02
Optimistic target level: 4.22
ImmunityBio Stock Forecast 12-04-2023.
Forecast target price for 12-04-2023: $3.94.
Negative dynamics for ImmunityBio shares will prevail with possible volatility of 6.706%.
Pessimistic target level: 3.78
Optimistic target level: 4.06
ImmunityBio Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $3.85.
Negative dynamics for ImmunityBio shares will prevail with possible volatility of 4.771%.
Pessimistic target level: 3.77
Optimistic target level: 3.95
ImmunityBio Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $4.00.
Positive dynamics for ImmunityBio shares will prevail with possible volatility of 4.729%.
Pessimistic target level: 3.90
Optimistic target level: 4.10
IBRX (IBRX) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 4.64 | 4.19 | 5.23 | 19.77 |
ImmunityBio forecast for this year
ImmunityBio Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $4.64236. Pessimistic: $4.19. Optimistic: $5.23
ImmunityBio (IBRX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.53 | 4.22 | 5.19 | 18.67 |
| Feb | 4.10 | 3.84 | 4.60 | 16.47 |
| Mar | 3.45 | 3.13 | 3.68 | 14.95 |
| Apr | 3.17 | 2.88 | 3.66 | 21.45 |
| May | 3.46 | 2.92 | 3.64 | 19.91 |
| Jun | 3.75 | 3.56 | 4.19 | 15.06 |
| Jul | 3.68 | 3.53 | 4.25 | 16.93 |
| Aug | 3.85 | 3.28 | 4.22 | 22.41 |
| Sep | 3.08 | 2.57 | 3.57 | 28.12 |
| Oct | 2.59 | 2.33 | 2.70 | 13.68 |
| Nov | 2.71 | 2.43 | 3.02 | 19.77 |
| Dec | 2.78 | 2.44 | 3.15 | 22.48 |
ImmunityBio (IBRX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.85 | 2.41 | 3.21 | 24.94 |
| Mar | 2.70 | 2.49 | 2.95 | 15.38 |
| Mar | 3.14 | 2.68 | 3.39 | 20.96 |
| Apr | 3.43 | 3.06 | 3.94 | 22.15 |
| May | 3.62 | 3.20 | 3.88 | 17.44 |
| Jun | 3.82 | 3.18 | 4.35 | 26.88 |
| Jul | 4.19 | 3.90 | 4.75 | 17.96 |
| Aug | 3.75 | 3.48 | 4.31 | 19.37 |
| Sep | 3.86 | 3.40 | 4.39 | 22.69 |
| Oct | 3.65 | 3.25 | 4.12 | 21.07 |
| Nov | 4.33 | 3.75 | 4.57 | 17.92 |
| Dec | 4.57 | 3.91 | 5.26 | 25.54 |
ImmunityBio (IBRX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.07 | 4.83 | 5.59 | 13.52 |
| Mar | 5.41 | 5.09 | 5.71 | 10.93 |
| Mar | 4.83 | 4.17 | 5.07 | 17.79 |
| Apr | 5.30 | 4.69 | 6.00 | 21.88 |
| May | 4.69 | 4.45 | 5.09 | 12.57 |
| Jun | 3.89 | 3.64 | 4.33 | 16.03 |
| Jul | 4.62 | 3.91 | 4.86 | 19.55 |
| Aug | 4.45 | 4.22 | 4.63 | 8.87 |
| Sep | 4.23 | 3.98 | 4.47 | 10.93 |
| Oct | 4.77 | 4.18 | 5.34 | 21.76 |
| Nov | 4.97 | 4.72 | 5.67 | 16.75 |
| Dec | 4.85 | 4.26 | 5.62 | 24.27 |
ImmunityBio (IBRX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.81 | 5.40 | 6.69 | 19.34 |
| Mar | 6.83 | 6.15 | 7.19 | 14.37 |
| Mar | 6.18 | 5.56 | 6.62 | 16.07 |
| Apr | 6.78 | 6.27 | 7.08 | 11.46 |
| May | 6.18 | 5.91 | 6.70 | 11.82 |
| Jun | 6.57 | 6.30 | 7.43 | 15.24 |
| Jul | 7.19 | 6.72 | 8.19 | 17.89 |
| Aug | 6.85 | 5.74 | 7.98 | 28.10 |
| Sep | 8.00 | 7.07 | 9.31 | 24.00 |
| Oct | 9.10 | 8.01 | 10.08 | 20.49 |
| Nov | 8.47 | 8.08 | 9.65 | 16.23 |
| Dec | 8.24 | 7.15 | 9.09 | 21.33 |
ImmunityBio information and performance
3530 JOHN HOPKINS COURT, SAN DIEGO, CA, US
Market capitalization of the ImmunityBio, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IBRX shares in the company outstanding by the market price of one share.
EBITDA of ImmunityBio is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
